Sort   by:  
 Page size 
UnknownVaccine effectiveness dynamics against influenza and SARS-CoV-2 in community-tested patients in France 2023-2024.
Not available
S-EPMC11980197 | biostudies-literature
UnknownInfluenza vaccine effectiveness against detected infection in the community, France, October 2024 to February 2025.
Not available
S-EPMC11843621 | biostudies-literature
UnknownCommunity and Hospital‐Based Laboratory Surveillance for Influenza, Respiratory Syncytial Virus, and SARS‐CoV‐2 During the 2023–2024 Season, Lyon, France
Not available
S-EPMC12396161 | biostudies-literature
UnknownInfluenza vaccine effectiveness and genetic diversity: insights from end-of-season community surveillance, France, 2024-2025.
Not available
S-EPMC12517415 | biostudies-literature
UnknownAge Differences in Comorbidities, Presenting Symptoms, and Outcomes of Influenza Illness Requiring Hospitalization: A Worldwide Perspective From the Global Influenza Hospital Surveillance Network.
Not available
S-EPMC10296081 | biostudies-literature
UnknownComplicated hospitalization due to influenza: results from the Global Hospital Influenza Network for the 2017-2018 season.
Not available
S-EPMC7330273 | biostudies-literature
UnknownPerceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts.
Not available
S-EPMC11665388 | biostudies-literature
UnknownLack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection.
Not available
S-EPMC11215417 | biostudies-literature
UnknownRare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Not available
S-EPMC10074346 | biostudies-literature
UnknownImmunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Not available
S-EPMC10867612 | biostudies-literature
Sort   by:  
 Page size